RCTdesign.org : About Us
Scott S. Emerson, MD PhD
Professor
Department of Biostatistics
University of Washington
webpage: http://www.emersonstatistics.com
email: scott@RCTdesign.org
Scott's educational background includes a Bachelor's degree in Physics, a Masters degree in Computer Science and a Medical degree, all from the University of Virginia. He completed his Ph.D. in Biostatistics at the University of Washington, where he now serves as a Professor of Biostatistics. His research interests include clinical trials, sequential testing, survival analysis, categorical data, nonparametric Bayesian statistics, and classification and regression trees.
Daniel L. Gillen, PhD
Associate Professor
Department of Statistics
University of California, Irvine
webpage: http://www.ics.uci.edu/~dgillen
email: dan@RCTdesign.org
The primary focus of Dan’s research is in the development of statistical methodology for censored survival data and group sequential methods for the design and analysis of clinical trials. In particular, research regarding the statistical foundations of much of today's commonly used survival analysis methods is a central focus of his work. Dan’s methodologic research is motivated by applications stemming from a multitude of clinical disciplines. He has chaired and served on multiple independent data and safety monitoring committees for multi-site international clinical trials as well as Reproductive Health and Cardio-Renal FDA advisory committees.
John M. Kittelson, PhD
Associate Professor
Department of Biostatistics and Informatics
University of Colorado, Denver
webpage: http://tinyurl.com/jkittelson
email: john@RCTdesign.org
John’s research interests are in clinical trial design and monitoring with particular interest in endpoint specification in trials with multiple outcomes including longitudinally-measured effects and bivariate endpoints. He is interested in methods that highlight the overlap, similarities, and evaluation of various approaches to group sequential trial design. John has extensive experience in collaborative biostatistics and clinical trials including industry collaborations, NIH-sponsored trials, and service as an FDA advisor.
Sarah C. Emerson, PhD
Department of Statistics
Oregon State University
webpage: http://www.stat.oregonstate.edu/people/emerson
email: sarah@RCTdesign.org
Sarah received her PhD from Stanford University before completing a postdoc at Harvard Biostatistics and joining the faculty in the Department of Statistics at Oregon State University. Her research interests include large sample theory, group sequential methods, adaptive trial design and monitoring, and survival analysis.
Gregory P. Levin, Ph.D.
Department of Biostatistics
University of Washington
webpage: http://students.washington.edu/glevin11
email: greg@RCTdesign.org
Greg completed his Ph.D. in Biostatistics at the University of Washington in 2011 and is currently at FDA/CDER. His methodologic research interests include clinical trials, sequential testing, and adaptive design and inference. He enjoys collaborating with investigators from multiple disciplines, and has research experience primarily in endocrinology.
We are a group of biostatistical researchers who have combined experience of more than 75 years investigating methodology for the design, conduct, analysis, and reporting of clinical trials. Results of our NIH (NCI, NHLBI, NIDDK, and NIA) and industry funded research formed the core of the S+SeqTrial package in the S-Plus statistical language. Through an agreement between us and Tibco, Inc., this package has recently been ported to R and is being licensed by us free of charge to all interested users. We welcome all queries and suggestions about ways to make the RCTdesign.org website more useful to users.